Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jan;41(1):68-80.
doi: 10.1007/s11239-015-1318-z.

Guidance for the use of thrombolytic therapy for the treatment of venous thromboembolism

Affiliations
Review

Guidance for the use of thrombolytic therapy for the treatment of venous thromboembolism

Suresh Vedantham et al. J Thromb Thrombolysis. 2016 Jan.

Abstract

Patients with venous thromboembolism (VTE) are prone to the development of both short-term and long-term complications that can substantially affect their functional capacity and quality of life. Patients with deep vein thrombosis (DVT) often develop recurrent VTE or the post-thrombotic syndrome, whereas patients with pulmonary embolism (PE) can develop long-term symptoms and functional limitations along a broad spectrum extending to full-blown chronic thromboembolic pulmonary hypertension. Clinicians who care for patients showing severe clinical manifestations of DVT and PE are often faced with challenging decisions concerning whether and how to escalate to more aggressive treatments such as those involving the use of thrombolytic drugs. The purpose of this chapter is to provide guidance on how best to individualize care to these patients.

Keywords: Anticoagulants; Direct oral anticoagulants (DOAC); New oral anticoagulants (NOAC); Pulmonary embolism; Thrombolytic therapy; Venous thromboembolism.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
An integrated algorithm for risk stratification for patients with acute pulmonary embolism (PE). RV right ventricular; LV left ventricular; CT computed tomography; IVC inferior vena cava
Fig. 2
Fig. 2
Risk stratification for patients with acute lower extremity proximal DVT

References

    1. Huang W, Goldberg RJ, Anderson FA, Kiefe CI, Spence FA. Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE Study (1985–2009) Am J Med. 2014;127(9):829–839:e5. doi: 10.1016/j.amjmed.2014.03.041. - DOI - PMC - PubMed
    1. Raffini L, Huang YS, Witmer C, Feudtner D. Dramatic increase in venous thromboembolism in children’s hospitals in the United States from 2001 to 2007. Pediatrics. 2009;124(4):1001–1008. doi: 10.1542/peds.2009-0768. - DOI - PubMed
    1. The surgeon general’s call to action to prevent deep vein thrombosis and pulmonary embolism. U.S. Department of Health and Human Services (2008) www.Surgeongeneral.Gov/topics/deepvein/calltoaction/call-to-action-on-dv... - PubMed
    1. Casazza F, Becattini C, Bongarzoni A, Cuccia C, Roncon L, Favretto G, Zonzin P, Pignataro L, Agnelli G. Clinical features and short term outcomes of patients with acute pulmonary embolism. The italian pulmonary embolism registry (iper) Thromb Res. 2012;130:847–852. doi: 10.1016/j.thromres.2012.08.292. - DOI - PubMed
    1. Becattini C, Casazza F, Forgione C, Porro F, Fadin BM, Stucchi A, Lignani A, Conte L, Imperadore F, Bongarzoni A, Agnelli G. Acute pulmonary embolism: external validation of an integrated risk stratification model. Chest. 2013;144:1539–1545. doi: 10.1378/chest.12-2938. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources